- ISIN
- US28414H1032
- CUSIP
- 28414H103
- Sector
- Healthcare
- IPO Date
- Sep 20, 2018
Highlights
- Market Cap
- $11.73B
- Enterprise Value
- $15.37B
- EPS (TTM)
- -$0.48
- Total Revenue (TTM)
- $4.89B
- Gross Profit (TTM)
- $2.42B
- EBITDA (TTM)
- $755.00M
- Year Range
- $13.39 - $27.72
- Target Price
- $28.00
- ROA (TTM)
- -1.83%
- ROE (TTM)
- -3.72%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ELAN Performance Chart
Elanco Animal Health Incorporated (ELAN) is up 2.4% since the beginning of the year. At $23 per share, ELAN is trading 16.4% below its 52-week high of $28. Investors who bought $1,000 worth of ELAN shares 5 years ago would now be looking at an investment worth $662.
Loading charts...
Returns By Period
Elanco Animal Health Incorporated (ELAN) has returned 2.43% so far this year and 73.63% over the past 12 months.
Elanco Animal Health Incorporated
- 1D
- -3.01%
- 1M
- 6.67%
- YTD
- 2.43%
- 6M
- 4.32%
- 1Y
- 73.63%
- 3Y*
- 33.15%
- 5Y*
- -7.91%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -1.44%
- 1M
- -1.45%
- YTD
- 7.60%
- 6M
- 6.59%
- 1Y
- 22.24%
- 3Y*
- 19.20%
- 5Y*
- 11.54%
- 10Y*
- 13.71%
ELAN Monthly Returns History
Based on dividend-adjusted daily data since Sep 20, 2018, ELAN's average daily return is +0.02%, while the average monthly return is +0.45%. At this rate, an investment would double in approximately 12.9 years.
Historically, 48% of months were positive and 52% were negative. The best month was May 2025 with a return of +41.8%, while the worst month was Aug 2022 at -25.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ELAN closed higher 48% of trading days. The best single day was May 7, 2025 with a return of +26.3%, while the worst single day was Jun 27, 2024 at -20.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.41% | 9.63% | -9.36% | -6.52% | 6.62% | -2.81% | 2.43% | ||||||
| 2025 | -0.66% | -7.15% | -6.00% | -9.71% | 41.77% | 6.25% | -4.20% | 34.14% | 9.75% | 9.98% | 5.06% | -2.75% | 86.87% |
| 2024 | -1.07% | 7.80% | 2.45% | -19.16% | 34.35% | -18.38% | -9.63% | 18.63% | -5.04% | -13.96% | 4.51% | -8.33% | -18.72% |
| 2023 | 12.36% | -16.46% | -18.05% | 0.74% | -13.94% | 23.44% | 19.98% | 1.08% | -7.87% | -21.62% | 33.71% | 26.49% | 21.93% |
| 2022 | -8.25% | 9.10% | -8.17% | -2.99% | -6.36% | -17.17% | 3.21% | -25.32% | -17.98% | 6.29% | -2.43% | -5.05% | -56.94% |
| 2021 | -5.35% | 13.19% | -10.38% | 7.67% | 13.47% | -3.59% | 5.13% | -8.47% | -4.46% | 3.10% | -12.59% | -1.25% | -7.47% |
Benchmark Metrics
Elanco Animal Health Incorporated has an annualized alpha of -9.30%, beta of 1.09, and R2 of 0.24 versus S&P 500 Index. Calculated based on daily prices since September 20, 2018.
- This stock participated in 158.79% of S&P 500 Index downside but only 109.59% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.24 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -9.30%
- Beta
- 1.09
- R²
- 0.24
- Upside Capture
- 109.59%
- Downside Capture
- 158.79%
Return for Risk
Risk / Return Rank
ELAN ranks 84 for risk / return — in the top 84% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ELAN | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.11 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.32 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 2.82 | 2.46 | +0.37 |
| Martin ratioReturn relative to average drawdown | 8.92 | 10.92 | -2.00 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Elanco Animal Health Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Elanco Animal Health Incorporated was 78.00%, occurring on May 30, 2023. The portfolio has not yet recovered.
The current Elanco Animal Health Incorporated drawdown is 36.87%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -78.00%May 2023 | 1y 9mo | — | 4y 10moAug 2021 - now |
COVID crash2020 | -53.91%Mar 2020 | 1y 5mo | 1y 4mo | 2y 9moSep 2018 - Jul 2021 |
Rate-hike selloffLate 2018 | -5.28%Sep 2018 | 0s | 6d | 6dSep 2018 - Sep 2018 |
2021 pullback2021 | -1.89%Jul 2021 | 0s | 2d | 2dJul 2021 - Jul 2021 |
2021 pullback2021 | -0.46%Jul 2021 | 1d | 4d | 5dJul 2021 - Aug 2021 |
Drawdown Indicators
| ELAN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.00% | -56.78% | -21.22% |
Max Drawdown (1Y)Largest decline over 1 year | -26.23% | -9.10% | -17.13% |
Max Drawdown (3Y)Largest decline over 3 years | -56.10% | -18.90% | -37.20% |
Max Drawdown (5Y)Largest decline over 5 years | -78.00% | -25.43% | -52.57% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -36.87% | -3.21% | -33.66% |
Average DrawdownAverage peak-to-trough decline | -39.76% | -10.71% | -29.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.28% | 2.04% | +6.24% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Elanco Animal Health Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Elanco Animal Health Incorporated is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ELAN relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ELAN has a P/S ratio of 2.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ELAN in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ELAN has a P/B value of 1.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ELAN
Add Elanco Animal Health Incorporated to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ELAN